Oct
2026
Fiera Milano, Italy
Visit us
stand 20K17, Finished Dosage & Formulation

Yuxi Walvax Biotechnology Co., Ltd.

Exhibitor at CPHI Milan 2026
About Us

Founded in 2001, Walvax Biotechnology Co. Ltd. is mainly engaged in research and development, manufacturing and distribution of safe and efficacious human vaccines. Walvax is a leading public listed company in China and has successfully developed 9 licensed vaccines (13 presentations). Among the 9 licensed products, Walvax has world’s 2nd approved PCV-13, 4th approved mRNA Covid-19 vaccine and 5th approved HPV vaccine. 

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2023
  • Employees:
    1000 - 4999
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 20K17, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026